Skip to main content

Table 1 Mutual relations of investigated genes

From: Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer

 

KRAS

NRAS

BRAF

PIK3CA

KRAS

NRAS

0.15 (0.03–0.71), 0.0065**

BRAF

0.15 (0.04–0.47), 0.0002***

0.47 (0.01–3.33), 0.6993

PIK3CA

2.97 (1.27–7.40), 0.0076**

2.18 (0.47–8.03), 0.2517

1.65 (0.50–4.72), 0.3930

  1. Values represent odds ratios with 95% CI in parentheses, p-values are in italics if < 0.05, and highlighted with one asterisk if < 0.05, two if < 0.01, or three if < 0.001